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The number of people suffering from diabetes is on the
increase due to population growth, aging, urbanization, and
increasing obesity and physical inactivity. The prevalence
of diabetes worldwide was estimated to be 2.8% in 2000
and 4.4% in 2030. The total number of people with dia-
betes is anticipated to rise from 171 million in 2000 to 366
million in 2030 (Wild S. et al. Diabetes Care 2004;27:
1047–1053).
Diabetes mellitus is a complex disease characterized by
absolute insulin deficiency or resistance leading to hyper-
glycemia. Two major forms of diabetes exist, namely type 1
diabetes mellitus (T1DM) and type 2 diabetes mellitus
(T2DM). T1DM occurs when the insulin-producing b-cells
in the pancreas are destroyed, resulting in insufficient
insulin production. T2DM is caused by development of
cellular resistance to insulin combined with insufficient
insulin production. T2DM is commonly linked to obesity,
which can cause insulin resistance. Diabetic patients show
altered metabolism of glucose, fat and protein. These met-
abolic dysfunctions result in a range of long-term effects
known as ‘‘diabetic complications’’. These manifest itself in
multiple disorders in for instance the vasculature, different
organs and inflammatory cells. This special issue focuses on
the mechanisms and effects of apoptosis in diabetes on a
(sub)cellular level in the pancreas and other organs.
Thomas H. et al. discuss apoptosis of beta cells that
occurs both in T1DM and T2DM as well as in transplanted
islets. In T1DM, b-cells are destroyed by immunological
mechanisms, whereas in T2DM metabolic abnormalities
contribute to b-cell failure and subsequent apoptosis.
Regardless of the diabetes type, highly conserved intra-
cellular pathways of apoptosis are triggered. In their review
Thomas et al. will outline these molecular mediators of
b-cell apoptosis and the intracellular pathways activated.
Szabadkai G. et al. focus on mitochondrial dysfunction
and its role in the pathogenesis of the survival/death path-
ways in both in T1DM and T2DM. They discuss the
apparently distinct mechanisms governing b-cell life/death
decisions during the development of diabetes and provide a
remarkable example where remote metabolic, immune and
stress signaling meet with mitochondria mediated apoptotic/
necrotic death pathways to determine the fate of the b-cell.
Furthermore, they clarify that deranged glucose stimulated
insulin secretion (GSIS) and over-nutrition-induced apop-
totic/necrotic b-cell death are the result of mitochondrial
dysfunction, representing hallmarks of T2DM.
Endoplasmic reticulum (ER) stress is increasingly acknowl-
edged as an important mechanism in the development of dia-
betes. Van der Kallen C.J.H. et al. explain that ER stress is
important not only for b-cell loss but also for insulin resistance.
They highlight the role of ER stress-induced apoptosis in liver
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and adipose tissue and discuss the exact interactions between
environmental signals, ER stress and apoptosis in these organs.
Ryan A. et al. focus on the importance of inflammation
in the development of diabetes. In addition, experiments
have shown that inflammation also plays a prominent role
in diabetes related target organ damage, in which both
elements of the innate and the adaptive immune system are
involved. They describe how inflammatory cell-mediated
apoptosis contributes to this target organ damage, from
b-cell destruction to both micro- and macrovascular dis-
ease complications.
An important target organ in diabetes is the kidney.
Hyperglycemia can induce apoptosis of renal cells and
result in diabetic nephropathy. Wagener F.A.D.T.G. et al.
show the importance of redox balance shifts in renal cells
in diabetes related kidney damage. Reactive oxygen spe-
cies (ROS) lead to considerable cellular damage and to a
point of no return in apoptosis when insufficient cytopro-
tective and ROS scavenging molecules are available. Here,
they discuss mechanisms of apoptosis and several strate-
gies that have been tested to prevent apoptosis in the dia-
betic kidney.
Another important target organ in diabetes is the liver. End
stage liver disease is characterized by fibrosis or cirrhosis and
occurs more often in patients with insulin resistance than in
patients with physiological insulin sensitivity. In their review
Schattenberg J.M. et al., focus on the molecular mechanisms
that connect insulin resistance with hepatocellular injury. The
mechanisms that advance hepatocellular injury, related to
decreased insulin sensitivity, are not well known. Here, the
authors summarize insulin signaling in the context of liver
disease and apoptotic hepatocellular injury and underline the
importance of understanding such signaling with respect to
therapy development.
Diabetes also affects the neural system, including its
development. Chappell J.H. et al. discuss defects of the
neural tube resulting from diabetic pregnancy. These
defects are associated with apoptosis early in its formation.
Maternal diabetes inhibits expression of the Pax3 gene that
encodes a transcription factor which is expressed in neural
crest and neuroepithelial cells. As a result of insufficient
Pax3, cardiac neural crest and neuroepithelial cells undergo
apoptosis.
In addition to hyperglycemia, elevated systemic levels of
fatty acids are considered significant contributors towards
the pathophysiological aspects associated with insulin
resistance. In their paper, Kusminski C.M. et al. explain that
over accumulation of unoxidized long-chain fatty acids can
result in a lipid ‘spill over’ to non-adipose tissues, such as the
liver, muscle, heart and pancreatic-islets. This ectopic lipid
deposition can promote metabolically relevant cellular dys-
function (lipotoxicity) and programmed cell-death (lipoa-
poptosis). The authors focus on how both of these processes
are major mediators of insulin resistance and diabetes.
This collection of excellent reviews highlights the
importance of apoptosis in the induction of diabetes and in
the pathophysiology of different diabetes related complica-
tions. Understanding these processes can offer new targets
for therapeutic intervention and are of increasing necessity,
regarding the growing world-wide burden of diabetes.
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